Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial-Reference-Cited by-同舟云学术

Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial

Published:2016-05-26 Issue:10 Volume:57 Page:1505-1511
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Bodet-Milin Caroline,Faivre-Chauvet Alain,Carlier Thomas,Rauscher Aurore,Bourgeois Mickael,Cerato Evelyne,Rohmer Vincent,Couturier Olivier,Drui Delphine,Goldenberg David M.,Sharkey Robert M.,Barbet Jacques,Kraeber-Bodere Francoise

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level

2. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

3. Clinical Value of 18-Fluorine-Fluorodihydroxyphenylalanine Positron Emission Tomography/Computed Tomography in the Follow-Up of Medullary Thyroid Carcinoma

4. Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer

5. Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer;Molecular Cancer Therapeutics;2024-07-04

3. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies;Pharmaceuticals;2024-04-16

4. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review;Nuclear Medicine Communications;2023-09-29

5. Cell-based relay delivery strategy in biomedical applications;Advanced Drug Delivery Reviews;2023-07